A detailed history of Mount Vernon Associates Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Mount Vernon Associates Inc holds 940 shares of LLY stock, worth $721,694. This represents 0.69% of its overall portfolio holdings.

Number of Shares
940
Previous 540 74.07%
Holding current value
$721,694
Previous $489,000 70.14%
% of portfolio
0.69%
Previous 0.43%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$772.14 - $960.02 $308,856 - $384,008
400 Added 74.07%
940 $832,000
Q2 2024

Jul 19, 2024

SELL
$724.87 - $909.04 $398,678 - $499,972
-550 Reduced 50.46%
540 $489,000
Q1 2024

Apr 22, 2024

SELL
$592.2 - $792.28 $17,766 - $23,768
-30 Reduced 2.68%
1,090 $847,000
Q3 2023

Oct 24, 2023

SELL
$434.7 - $599.3 $4,347 - $5,993
-10 Reduced 0.88%
1,120 $602,000
Q2 2023

Jul 24, 2023

SELL
$350.74 - $468.98 $8,417 - $11,255
-24 Reduced 2.08%
1,130 $530,000
Q3 2021

Oct 20, 2021

SELL
$221.6 - $272.71 $37,672 - $46,360
-170 Reduced 12.84%
1,154 $267,000
Q4 2020

Jan 25, 2021

BUY
$130.46 - $172.63 $172,729 - $228,562
1,324 New
1,324 $224,000
Q3 2020

Oct 23, 2020

SELL
$146.22 - $169.13 $193,595 - $223,928
-1,324 Closed
0 $0
Q2 2020

Jul 27, 2020

SELL
$136.42 - $164.18 $68,210 - $82,090
-500 Reduced 27.41%
1,324 $217,000
Q2 2019

Jul 30, 2019

SELL
$110.79 - $129.32 $135,606 - $158,287
-1,224 Reduced 40.16%
1,824 $202,000
Q2 2019

Jul 25, 2019

BUY
$110.79 - $129.32 $135,606 - $158,287
1,224 Added 67.11%
3,048 $338,000
Q4 2018

Jan 24, 2019

BUY
$105.9 - $118.64 $193,161 - $216,399
1,824 New
1,824 $211,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mount Vernon Associates Inc Portfolio

Follow Mount Vernon Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mount Vernon Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mount Vernon Associates Inc with notifications on news.